13F-HR filed by Prosight Management, LP
Prosight Management, LP filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 44 holding rows worth $359,452,762.
- Accession
- 0001420506-24-000996
- Filer
- CIK 1617201
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 44 entries on the cover page, a total value of $359,452,762 stated on the cover page (in dollars after the unit check, H1), rows summing to $359,452,762 with VALUE read as dollars as filed, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 3,725,000 | $33,301,500 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 7,050,300 | $31,655,847 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 931,512 | $29,994,686 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 4,017,301 | $24,385,017 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 960,000 | $20,476,800 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 1,860,000 | $19,604,400 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 589,530 | $18,228,268 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 245,000 | $17,176,950 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 180,000 | $15,687,000 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 418,261 | $12,196,491 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 465,000 | $11,680,800 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 470,000 | $9,696,100 | dollars as filed | |
| KELLY SVCS INC | 488152208 | CL A | 348,686 | $8,731,097 | dollars as filed | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 1,790,000 | $8,108,700 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 3,659,755 | $7,539,095 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 1,400,000 | $7,112,000 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 195,000 | $6,300,450 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 215,000 | $5,966,250 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 215,000 | $5,820,050 | dollars as filed | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 30,000 | $5,473,800 | dollars as filed | |
| MARAVAI LIFESCIENCES HLDGS A | 56600D107 | COMMON STOCK | 599,460 | $5,197,318 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 410,948 | $4,323,173 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 170,469 | $4,222,517 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 30,500 | $4,206,560 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 100,617 | $3,948,211 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 450,000 | $3,735,000 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 555,500 | $3,732,960 | dollars as filed | |
| OPTION CARE HEALTH INC COM NEW | 68404L201 | Stock | 100,000 | $3,354,000 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 39,046 | $3,201,772 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 23,000 | $3,190,100 | dollars as filed | |
| BARRETT BUSINESS SVCS INC | 068463108 | COM | 24,000 | $3,041,280 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 983,200 | $2,998,760 | dollars as filed | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 94,362 | $2,757,258 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 18,908 | $2,495,478 | dollars as filed | |
| MURAL ONCOLOGY PUB LTD CO | G63365103 | ORD SHS | 400,000 | $1,956,000 | dollars as filed | |
| LENZ THERAPEUTICS INC | 52635N103 | COM | 65,000 | $1,451,450 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 30,000 | $1,125,900 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 75,000 | $1,121,250 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 250,000 | $910,000 | dollars as filed | |
| PRIVIA HEALTH GROUP INC | 74276R102 | COM | 45,000 | $881,550 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 963,598 | $868,780 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 25,000 | $731,000 | dollars as filed | |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 566,519 | $725,144 | dollars as filed | |
| ABSCI CORPORATION | 00091E109 | COM | 25,000 | $142,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-000996 | this filing | 2024-05-15 | acceptance time not in the bulk data set |